Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation

Bolik KV, Hellmann J, Maschauer S, Neu E, Einsiedel J, Riss P, Vogg N, König J, Fromm M, Hübner H, Gmeiner P, Prante O (2024)

Publication Language: English

Publication Type: Journal article

Publication year: 2024

Journal

Book Volume: 14

Article Number: 80

DOI: 10.1186/s13550-024-01141-2

Abstract

Background: The orexin receptor (OXR) plays a role in drug addiction and is aberrantly expressed in colorectal tumors. Subtype-selective OXR PET ligands suitable for in vivo use have not yet been reported. This work reports the development of ¹⁸F-labeled OXR PET ligand candidates derived from the OXR antagonist suvorexant and the OX1R-selective antagonist JH112. Results: Computational analysis predicted that fluorine substitution (1e) and introduction of the fluorobenzothiazole scaffold (1f) would be suitable for maintaining high OX1R affinity. After multi-step synthesis of 1a–1f, in vitro OXR binding studies confirmed the molecular dynamics calculations and revealed single-digit nanomolar OX1R affinities for 1a–f, ranging from 0.69 to 2.5 nM. The benzothiazole 1f showed high OX1R affinity (Ki = 0.69 nM), along with 77-fold subtype selectivity over OX2R. Cu-mediated ¹⁸F-fluorination of boroxine precursors allowed for a shortened reaction time of 5 min to provide the non-selective OXR ligand [¹⁸F]1c and its selective OX1R congener [¹⁸F]1f in activity yields of 14% and 22%, respectively, within a total synthesis time of 52–76 min. [¹⁸F]1c and [¹⁸F]1f were stable in plasma and serum in vitro, with logD7.4 of 2.28 ([¹⁸F]1c) and 2.37 ([¹⁸F]1f), and high plasma protein binding of 66% and 77%, respectively. Dynamic PET imaging in rats showed similar brain uptake of [¹⁸F]1c (0.17%ID/g) and [¹⁸F]1f (0.15%ID/g). However, preinjection of suvorexant did not significantly block [¹⁸F]1c or [¹⁸F]1f uptake in the rat brain. Pretreatment with cyclosporine A to study the role of P-glycoprotein (P-gp) in limiting brain accumulation moderately increased brain uptake of [¹⁸F]1c and [¹⁸F]1f. Accordingly, in vitro experiments demonstrated that the P-gp inhibitor zosuquidar only moderately inhibited polarized, basal to apical transport of 1c (p < 0.05) and had no effect on the transport of 1f, indicating that P-gp does not play a relevant role in brain accumulation of [¹⁸F]1c and [¹⁸F]1f in vivo. Conclusions: The in vitro and in vivo results of [¹⁸F]1c and [¹⁸F]1f provide a solid basis for further development of suitable OXR PET ligands for brain imaging.

Authors with CRIS profile

Additional Organisation(s)

Involved external institutions

Johannes Gutenberg-Universität Mainz (JGU) Germany (DE)

How to cite

APA:

Bolik, K.-V., Hellmann, J., Maschauer, S., Neu, E., Einsiedel, J., Riss, P.,... Prante, O. (2024). Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation. EJNMMI Research, 14. https://doi.org/10.1186/s13550-024-01141-2

MLA:

Bolik, Kim-Viktoria, et al. "Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation." EJNMMI Research 14 (2024).

BibTeX: Download